AN2 THERAPEUTICS, INC.

Insiders AN2 Therapeutics, Inc.

Equities

ANTX

US0373261058

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-07 pm EDT			5-day change	1st Jan Change
2.03 ^USD	-2.87%		+2.01%	-90.09%

May. 16	Evercore ISI Adjusts Price Target on AN2 Therapeutics to $2 From $7, Maintains In-Line Rating	MT
May. 14	AN2 Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

An2 Therapeutics Insider Sold Shares Worth $1,911,410, According to a Recent SEC Filing	Jan. 22	MT
An2 Therapeutics Insider Sold Shares Worth $1,704,513, According to a Recent SEC Filing	23-10-04	MT
An2 Therapeutics Insider Sold Shares Worth $150,708, According to a Recent SEC Filing	23-09-29	MT
Insider Sell: An2 Therapeutics	23-09-08	MT
AN2 Therapeutics, Inc. Announces Executive Changes	23-09-08	CI
AN2 Therapeutics, Inc. Appoints Maggie Fitzpatrick to its Board of Directors	22-05-09	CI
Insider Buy: AN2 Therapeutics	22-04-01	MT
Insider Buy: AN2 Therapeutics	22-04-01	MT
AN2 Therapeutics, Inc. Appoints Patricia Martin and Stephanie Wong to the Board of Directors	22-01-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

fermer